Navigation Links
Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed

NEW YORK, March 26 /PRNewswire/ -- Golub Capital today announced that it has provided a $29.5 million one-loan debt financing (through Golub Capital's proprietary GOLD facility) in support of the recapitalization of ExtruMed, a market leader providing precision tubing solutions to the medical industry. Founded in 1990, and based in Placentia, Calif., ExtruMed's products are used in medical devices and technology serving various therapy areas including cardiology, vascular therapies, endosurgery, neurology, Ob/Gyn and urology. GOLD financings are proprietary Golub Capital One-Loan Debt facilities.

ExtruMed has been owned by Inverness Graham Investments and Wedbush Capital Partners since September 2005. The debt provided by Golub Capital will be used to refinance the company's existing debt and provide a cash dividend to the sponsors.

"We are very excited to have closed our first transaction with two private equity sponsors of the caliber of Inverness Graham and Wedbush Capital. We are pleased that we were able to provide them with the appropriate solution for their financing needs," said Golub Capital Managing Director Charlie Riceman. "ExtruMed is a true leader in its field. We have been extremely impressed with the deep knowledge and experience of the ExtruMed management team and are excited to watch ExtruMed continue to build out its capabilities and grow."

"We are pleased to close our first transaction with Golub Capital. The flexibility in structure and spirit of partnership demonstrated by Golub has contributed to a very efficient process. We are pleased to have them as partners in ExtruMed and look forward to future transactions together." says Scott Kehoe, a Managing Principal at Inverness Graham Investments.

Golub Capital lends to broad range of U.S.-based mid-market companies and initially invests between $5 million and $75 million with additional capital available for growth.

About Golub Capital

Golub Capital is an active provider of GOLD (Golub Capital's One-Loan Debt Facility), senior and subordinated debt, second lien debt, preferred stock, and co-investment equity to middle market companies. The firm is committed to being a value-added and user-friendly partner to owners, senior management and transaction sponsors. With a broad investment mandate and long-term time horizon, Golub Capital has a high level of flexibility in structuring investments. For more information, please visit

SOURCE Golub Capital
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross & Blue Shield Association
2. Super Model Cindy Crawford will be Honored at DKMS Linked Against Leukemia Gala on May 7th at Capitale
3. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
4. InforMedix Retains Murdock Capital Partners
5. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
6. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
7. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
8. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
9. Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
10. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
11. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: